EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Management of COVID-19 Infection in a Small Bowel Transplant Recipient: A Case Report

Tzu-Yu Chiu, Chia-Chi Weng, Siu Chung Ha, Huang-Wen Tsai, Chee-Chee Koh, Yun Chen

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.05.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Tzu-Yu Chiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taiwan. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has caused millions of people to become infected worldwide. Some patients may have disease progression and may need treatment with an anti-COVID-19 agent, hospitalization, and even intensive care. The risk factors for disease progression include old age, diabetes mellitus, pulmonary disease, cardiac disease, immunodeficiency, and immunosuppressant treatment. Therefore, managing COVID-19 infection in transplant patients under immunosuppressant treatments needs specific consideration, especially the side effects of anti-COVID-19 agents and the interaction between immunosuppressants and anti-COVID-19 agents. In this report, we present the case of a small bowel transplant patient who had a COVID-19 infection. The patient was initially treated for paxlovid, and she developed bloody stools and dizziness. The treatment was then changed to molnupiravir without discontinuation of tacrolimus. The patient recovered smoothly after a 5-day treatment with molnupiravir. Here, we discuss the management experience of such patients and review the relevant literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19FemaleHumansSARS-CoV-2Transplant RecipientsPandemicsImmunosuppressive AgentsDisease ProgressionDrug CombinationsLactamsLeucineNitrilesProlineRitonavirCytidineHydroxylamines

Substanzen

Immunosuppressive Agentsnirmatrelvir and ritonavir drug combinationDrug CombinationsLactamsLeucineNitrilesProlineRitonavirmolnupiravirCytidine

Autor:innen und Institutionen

  • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taiwan.
  • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taiwan; Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li, Taiwan.
  • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Chung-Li, Taiwan.
  • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Chung-Li, Taiwan. Electronic address: ychen@mail.femh.org.tw.

Zitieren

APA

Chiu, T. Y., Weng, C. C., Ha, S. C., Tsai, H. W., Koh, C. C., & Chen, Y. (2023). Management of COVID-19 Infection in a Small Bowel Transplant Recipient: A Case Report. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.05.008

Vancouver

Chiu TY, Weng CC, Ha SC, Tsai HW, Koh CC, Chen Y. Management of COVID-19 Infection in a Small Bowel Transplant Recipient: A Case Report. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.05.008

BibTeX
@article{Chiu2023,
  author = {Chiu, Tzu-Yu and Weng, Chia-Chi and Ha, Siu Chung and Tsai, Huang-Wen and Koh, Chee-Chee and Chen, Yun},
  title = {Management of COVID-19 Infection in a Small Bowel Transplant Recipient: A Case Report},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.05.008}
}
Kostenlos starten →